Table 1. Summary of Efficacy: Controlling Plasma Uric Acid.

	Rasburicase	Rasburicase + allopurinol	Allopurinol
Response rate (% of patients with plasma uric acid levels ≤ 7.5 mg/dL between days 3 and 7)	87%	78%	66%
Plasma uric acid response rate: patients at high risk for TLS	89%	–	68%
Plasma uric acid response rate: patients with baseline hyperuricemia	90%	–	53%
Time to plasma uric acid control for hyperuricemic patients	4 hr	4 hr	27 hr

Note. Information from Cortes et al. (2010); Dinnel et al. (2015); Maloney & Denno (2011); Sanofi-aventis US, LLC. (2019).